IPOPLUS

₹265.55

▼ -4.5 -1.67%

18 Jun 2026

NSE Listed · Healthcare

Suraksha Diagnostic Ltd. (SURAKSHA)

Volume: 1,695Avg Vol 1W: 1,498Avg Vol 1M: 2,74852W Range:₹224.1₹352.5
NSE BSE
₹265.55▼ 1.67%
Key Ratios
Updated 2h ago
Market Cap₹1,402 Cr
Current Price₹265.55
Previous Close₹270.05
High / Low (52w)₹352.5 / ₹224.1
Volume1,695
Avg Vol (1W)1,498
Avg Vol (1M)2,748
Stock P/E42.19
Book Value₹47
Dividend Yield0.19%
ROE13.15%
ROA7.01%
Revenue (TTM)—
Revenue Growth15.26%
Profit Margin10.37%
Total Debt₹3 Cr
Shares Outstanding5 Cr
Face Value₹2
EPS (TTM)₹1.21
P/B6.53
Debt / Equity0.53
50 DMA₹287.22
200 DMA₹273.21
Day change-1.67%
Price Chart
₹265.55▼ 10.74% · 1Y
₹325₹2281.7L
2025-10-01
2026-06-16

20-day avg volume: 3K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 15% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue₹81 Cr₹78 Cr₹79 Cr₹73 Cr₹65 Cr₹60 Cr₹67 Cr₹61 Cr₹55 Cr₹52 Cr₹60 Cr
EBITDA₹14 Cr₹13 Cr₹15 Cr₹15 Cr₹11 Cr₹10 Cr₹16 Cr₹13 Cr₹12 Cr₹8 Cr₹13 Cr
Net Profit₹6 Cr₹8 Cr₹9 Cr₹9 Cr₹7 Cr₹6 Cr₹10 Cr₹8 Cr₹7 Cr₹5 Cr₹8 Cr
EPS1.211.441.731.81.421.181.941.491.220.872.44
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹256 Cr₹222 Cr₹194 Cr₹225 Cr₹141 Cr₹159 Cr
EBITDA₹50 Cr₹41 Cr₹16 Cr₹35 Cr₹8 Cr₹23 Cr
Net Profit₹32 Cr₹24 Cr₹7 Cr₹24 Cr₹6 Cr₹15 Cr
EPS5.974.431.22278.4775178
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹334 Cr₹300 Cr₹281 Cr₹201 Cr₹171 Cr₹173 Cr
Total Liabilities₹123 Cr₹121 Cr₹126 Cr₹51 Cr₹45 Cr₹53 Cr
Equity₹210 Cr₹179 Cr₹155 Cr₹150 Cr₹126 Cr₹120 Cr
Total Debt₹3 Cr₹5 Cr₹8 Cr₹12 Cr₹10 Cr₹8 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹74 Cr₹69 Cr₹51 Cr₹47 Cr₹26 Cr
Investing₹-40 Cr₹-35 Cr₹-21 Cr₹-44 Cr₹-28 Cr
Financing₹-24 Cr₹-25 Cr₹-24 Cr₹1 Cr₹3 Cr
Free Cash Flow₹74 Cr₹69 Cr₹51 Cr₹47 Cr₹26 Cr
Shareholding
Promoter 49.1% Institutions 23.72% Public 27.19%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search